Jazz Pharmaceuticals Letterhead]Transition and Termination Agreement • November 5th, 2019 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations
This letter contains the Transition and Termination Agreement (the “Agreement”) between you and Jazz Pharmaceuticals, Inc. (the “Company”).
Jazz Pharmaceuticals Letterhead]Letter Agreement • November 5th, 2019 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • Delaware
This letter agreement (“Agreement”) sets forth the terms and conditions for accelerated vesting of your Stock Awards under certain circumstances. Terms not defined in this Agreement shall have the definitions set forth in your Amended and Restated Change in Control Severance Terms Agreement which is effective 15 May 2016 (the “CIC Severance Agreement”).
Jazz Pharmaceuticals Letterhead]Jazz Pharmaceuticals PLC • November 5th, 2019 • Pharmaceutical preparations
As was discussed with you, this letter agreement (the “Amendment”) provides the amended and restated terms covering your eligibility for cash severance benefits under certain circumstances related to a Change in Control. This Amendment is effective as of 15 May 2016, provided that it is signed by both you and Jazz Pharmaceuticals Ireland Limited by this date. This Amendment amends your contract of employment dated 14 May 2012 (the “Employment Contract”), and it supersedes and replaces the previous letter agreement dated 17 September 2012 which covered your eligibility for severance benefits. For purposes of this Amendment, you are referred to as the “Executive.” Your amended and restated severance benefits terms are set forth below.
